检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial.

K Alsaleh,H Al Zahwahry,A Bounedjar,M Oukkal,A Saadeddine,H Mahfouf,K Bouzid,A Bensalem,T Filali,H Abdel-Razeq,B Larbaoui,A Kandil,O Abulkhair,M Al Foheidi,M Ghosn,H Rasool,H Boussen,A Mezlini,A Haddaoui,J Ayari,M Al Ghamdi,H Errihani,N Abdel-Aziz,M Arafah,F Dabouz,M Bahadoor,S Kullab,J M Nabholtz

Journal of cancer research and clinical oncology（2023）

引用 0|浏览18
暂无评分
摘要
Neoadjuvant hormonal therapy is feasible in a selected population with a low RS score of < 31 CLINICAL TRIAL: NCT03447132.
更多
查看译文
关键词
21-gene breast recurrence score assay,Breast cancer,Fulvestrant,Neoadjuvant hormone therapy,Palbociclib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要